HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LAEKNA-B

14.540

+0.3802.68%

Volume:596.00K

Turnover:8.81M

Market Cap:6.48B

PE:-20.45

High:15.090

Open:14.500

Low:14.260

Close:14.160

52wk High:23.500

52wk Low:8.100

Shares:446.00M

HK Float Shares:446.00M

Volume Ratio:0.99

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.711

ROE:-34.59%

ROA:-19.92%

PB:8.01

PE(LYR):-20.45

PS:1234.31

Loading ...

Overview Company News Filings

LAEKNA-B (02105): First Patient Dosed in Phase I Multiple-Dose Expansion Study of LAE102 for Obesity Treatment

Laekna Inc. Begins Phase I Multiple Dose Study of LAE102 for Obesity Treatment

Laekna Completes Patient Enrollment In LAE002 Breast Cancer Study

MT Newswires Live

LAEKNA-B (02105): Enrollment Completed for Phase III Clinical Trial (AFFIRM-205) of LAE002 (Afuresertib) in HR+/HER2- Locally Advanced or Metastatic Breast Cancer

FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats up

LAEKNA-B (02105): Xie Ling and Zhou Jian Appointed as Members of Nomination and Corporate Governance Committee

Laekna Inc. Files Director List with HKEX

Laekna Inc. Appoints Xie Ling and Zhou Jian to Nomination and Corporate Governance Committee

HK Stock Movement | LAEKNA-B (02105) Rises Over 5% in Early Trading, LAE002 Expected to Submit NDA in First Half of 2026

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

Laekna, Inc. (02105) Reports Unchanged Share Structure in November 2025

Bulletin Express

HK Stock Movement | LAEKNA-B (02105) Surges Over 6%, Industry Expects LAE002's Peak Sales in China to Reach RMB 2 Billion

HK Stock Movement | LAIKNA-B (02105) Surges Over 15%, Up 40% This Month Following BD Deal for LAE002

FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats up

Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast

LAEKNA-B (02105) Surges Over 9% Again as Breast Cancer Drug Candidate LAE002 Secures 2.045 Billion Yuan BD Deal

HK Stock Movement | LAIKNA-B (02105) Rises Nearly 7% Against Market Trend, Secures RMB 2.045 Billion BD Deal for Star Breast Cancer Target, Strengthens Core Business in Muscle Gain and Fat Loss

HK Movers | Biomedical Stocks Jump With CStone Pharmaceuticals up 13%

Tiger Newspress

HK Movers | Biomedical Stocks Jump With BeOne Medicines and Biocytogen up 7%

Tiger Newspress

BUZZ-HK-listed Laekna jumps most in 7 weeks on Qilu licence deal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02105/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02105","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"LAEKNA-B","latestPrice":14.54,"timestamp":1774408888034,"preClose":14.16,"halted":0,"volume":596000,"delay":0,"changeRate":0.026836158192090325,"floatShares":446000000,"shares":446000000,"eps":-0.711066,"marketStatus":"Trading","change":0.38,"latestTime":"03-25 11:27:22","open":14.5,"high":15.09,"low":14.26,"amount":8806102,"amplitude":0.058616,"askPrice":14.6,"askSize":3000,"bidPrice":14.54,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-0.569,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1774411200000},"marketStatusCode":2,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":14.16,"openAndCloseTimeList":[[1774402200000,1774411200000],[1774414800000,1774425600000]],"volumeRatio":0.985153,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","floatShares":446000000,"roa":"-19.92%","roe":"-34.59%","lyrEps":-0.711066,"volumeRatio":0.985153,"shares":446000000,"dividePrice":0,"high":15.09,"amplitude":0.058616,"preClose":14.16,"low":14.26,"week52Low":8.1,"pbRate":"8.01","psRate":"1234.31","week52High":23.5,"institutionHeld":0,"latestPrice":14.54,"committee":-0.2,"eps":-0.711066,"divideRate":0,"volume":596000,"delay":0,"ttmEps":-0.569,"open":14.5,"prevYearClose":13.57,"prevWeekClose":15,"prevMonthClose":13.3,"prevQuarterClose":13.57,"fiveDayClose":14.85,"twentyDayClose":13.4,"sixtyDayClose":14.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02105\",params:#limit:5,,,undefined,":[{"date":"2026-03-18","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1773797400000,"name":null,"time":"","dateTimestamp":1773763200000,"actualEps":null},{"date":"2025-08-13","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755048600000,"name":null,"time":"","dateTimestamp":1755014400000,"actualEps":null},{"date":"2025-03-24","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-16","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723771800000,"name":null,"time":"Post Market","dateTimestamp":1723737600000,"actualEps":null},{"date":"2024-03-26","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02105\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02105\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1754323200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02105\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02105","date":"2026-03-24","current":-25.553603,"percent":0.21037,"low":-30.832985,"twenty":-21.860972,"median":-11.10107,"eighty":-5.557677,"high":-1.640852,"avg":-13.176231,"sd":7.962676,"marketCap":5922328243},"quantilePoints":[{"date":"2023-06-30","current":-7.785551,"twenty":-6.73679,"median":-5.163648,"eighty":-3.590506,"marketCap":6577091901},{"date":"2023-07-07","current":-6.912426,"twenty":-7.480081,"median":-7.023469,"eighty":-6.753459,"marketCap":5828099229},{"date":"2023-07-14","current":-6.415246,"twenty":-7.354402,"median":-6.80281,"eighty":-6.620389,"marketCap":5484810921},{"date":"2023-07-21","current":-6.50021,"twenty":-7.00126,"median":-6.637911,"eighty":-6.415921,"marketCap":5531622963},{"date":"2023-07-28","current":-6.387862,"twenty":-6.910347,"median":-6.626959,"eighty":-6.393338,"marketCap":5430196872},{"date":"2023-08-04","current":-6.872048,"twenty":-6.916775,"median":-6.645885,"eighty":-6.415921,"marketCap":5851505250},{"date":"2023-08-11","current":-8.062915,"twenty":-7.354402,"median":-6.732662,"eighty":-6.423028,"marketCap":6826756125},{"date":"2023-08-18","current":-6.496848,"twenty":-7.428921,"median":-6.729682,"eighty":-6.45189,"marketCap":5461404900},{"date":"2023-08-25","current":-8.440637,"twenty":-7.525288,"median":-6.804775,"eighty":-6.49752,"marketCap":6327427677},{"date":"2023-09-01","current":-9.089804,"twenty":-8.007442,"median":-6.902032,"eighty":-6.501491,"marketCap":6842360139},{"date":"2023-09-08","current":-6.586545,"twenty":-8.136633,"median":-6.907229,"eighty":-6.507456,"marketCap":4899660396},{"date":"2023-09-15","current":-5.932237,"twenty":-8.007442,"median":-6.869978,"eighty":-6.423028,"marketCap":4447143990},{"date":"2023-09-22","current":-6.606383,"twenty":-7.784235,"median":-6.883282,"eighty":-6.45189,"marketCap":4930868424},{"date":"2023-09-29","current":-7.14814,"twenty":-7.744431,"median":-6.894516,"eighty":-6.45189,"marketCap":5344374795},{"date":"2023-10-06","current":-7.631816,"twenty":-7.631816,"median":-6.912426,"eighty":-6.496848,"marketCap":5703267117},{"date":"2023-10-13","current":-8.856112,"twenty":-8.155063,"median":-6.923868,"eighty":-6.50021,"marketCap":6608299929},{"date":"2023-10-20","current":-8.199572,"twenty":-8.313082,"median":-7.000277,"eighty":-6.506614,"marketCap":6108971481},{"date":"2023-10-27","current":-9.816471,"twenty":-8.453817,"median":-7.029823,"eighty":-6.509983,"marketCap":7310480559},{"date":"2023-11-03","current":-11.65035,"twenty":-8.539495,"median":-7.190868,"eighty":-6.562195,"marketCap":8699237805},{"date":"2023-11-10","current":-10.973476,"twenty":-8.805599,"median":-7.285091,"eighty":-6.584244,"marketCap":8192107350},{"date":"2023-11-17","current":-11.729885,"twenty":-9.08956,"median":-7.4166,"eighty":-6.600627,"marketCap":8835772927},{"date":"2023-11-24","current":-11.685472,"twenty":-9.394133,"median":-7.490817,"eighty":-6.605936,"marketCap":8874782962},{"date":"2023-12-01","current":-9.84176,"twenty":-10.15546,"median":-7.577915,"eighty":-6.610422,"marketCap":7505530734},{"date":"2023-12-08","current":-7.796477,"twenty":-9.900606,"median":-7.778973,"eighty":-6.615093,"marketCap":5921723313},{"date":"2023-12-15","current":-9.518573,"twenty":-9.821529,"median":-7.782262,"eighty":-6.63353,"marketCap":7271470524},{"date":"2023-12-22","current":-9.095699,"twenty":-9.838318,"median":-7.864399,"eighty":-6.64429,"marketCap":6943786230},{"date":"2023-12-29","current":-10.114857,"twenty":-10.007865,"median":-8.108989,"eighty":-6.673018,"marketCap":7762996965},{"date":"2024-01-05","current":-7.064143,"twenty":-9.846254,"median":-7.963657,"eighty":-6.71691,"marketCap":5383384830},{"date":"2024-01-12","current":-6.507833,"twenty":-9.8409,"median":-7.785551,"eighty":-6.71691,"marketCap":4962076452},{"date":"2024-01-19","current":-6.147909,"twenty":-9.833261,"median":-7.674627,"eighty":-6.639506,"marketCap":4681204200},{"date":"2024-01-26","current":-4.037471,"twenty":-9.789285,"median":-7.606263,"eighty":-6.604594,"marketCap":3062287747},{"date":"2024-02-02","current":-1.910591,"twenty":-9.668744,"median":-7.523229,"eighty":-6.508431,"marketCap":1447272298},{"date":"2024-02-09","current":-1.972972,"twenty":-9.600955,"median":-7.449769,"eighty":-6.45189,"marketCap":1501886347},{"date":"2024-02-16","current":-2.11088,"twenty":-9.539168,"median":-7.4166,"eighty":-6.417948,"marketCap":1607213442},{"date":"2024-02-23","current":-1.782124,"twenty":-9.334553,"median":-7.285091,"eighty":-6.285716,"marketCap":1349747211},{"date":"2024-03-01","current":-3.73704,"twenty":-9.184661,"median":-7.220535,"eighty":-6.16588,"marketCap":2832128541},{"date":"2024-03-08","current":-3.812556,"twenty":-9.158571,"median":-7.14814,"eighty":-5.783471,"marketCap":2890643593},{"date":"2024-03-15","current":-3.774736,"twenty":-9.108268,"median":-7.054895,"eighty":-5.122231,"marketCap":2859435565},{"date":"2024-03-22","current":-3.314294,"twenty":-9.090983,"median":-7.029823,"eighty":-4.16949,"marketCap":2508345250},{"date":"2024-03-28","current":-5.557677,"twenty":-9.089621,"median":-7.000277,"eighty":-4.108477,"marketCap":2219670991},{"date":"2024-04-05","current":-4.994454,"twenty":-9.061533,"median":-6.958518,"eighty":-4.159233,"marketCap":1993412788},{"date":"2024-04-12","current":-4.698569,"twenty":-8.939101,"median":-6.914215,"eighty":-4.187247,"marketCap":1876382683},{"date":"2024-04-19","current":-5.074098,"twenty":-8.895252,"median":-6.907229,"eighty":-4.270544,"marketCap":2024620816},{"date":"2024-04-26","current":-6.049449,"twenty":-8.886537,"median":-6.872048,"eighty":-4.439166,"marketCap":2410820163},{"date":"2024-05-03","current":-6.122202,"twenty":-8.8768,"median":-6.815159,"eighty":-4.698569,"marketCap":2438127187},{"date":"2024-05-10","current":-6.43996,"twenty":-8.86224,"median":-6.755587,"eighty":-4.994454,"marketCap":2570761306},{"date":"2024-05-17","current":-7.203002,"twenty":-8.857338,"median":-6.782134,"eighty":-5.0499,"marketCap":2871138576},{"date":"2024-05-24","current":-4.794357,"twenty":-8.851703,"median":-6.739573,"eighty":-4.885401,"marketCap":2754108471},{"date":"2024-05-31","current":-4.572395,"twenty":-8.804497,"median":-6.721699,"eighty":-4.757241,"marketCap":2629276359},{"date":"2024-06-07","current":-4.421848,"twenty":-8.685949,"median":-6.645885,"eighty":-4.615745,"marketCap":2539553278},{"date":"2024-06-14","current":-3.882014,"twenty":-8.64394,"median":-6.616008,"eighty":-4.537135,"marketCap":2227472998},{"date":"2024-06-21","current":-3.862906,"twenty":-8.598267,"median":-6.605265,"eighty":-4.402835,"marketCap":2211868984},{"date":"2024-06-28","current":-3.550986,"twenty":-8.56584,"median":-6.575038,"eighty":-4.108477,"marketCap":2032422823},{"date":"2024-07-05","current":-3.292704,"twenty":-8.553381,"median":-6.507833,"eighty":-3.906941,"marketCap":1884184690},{"date":"2024-07-12","current":-3.669077,"twenty":-8.541472,"median":-6.498529,"eighty":-3.863311,"marketCap":2102640886},{"date":"2024-07-19","current":-2.927038,"twenty":-8.530589,"median":-6.44065,"eighty":-3.81922,"marketCap":1677431505},{"date":"2024-07-26","current":-2.773786,"twenty":-8.516747,"median":-6.41868,"eighty":-3.760814,"marketCap":1595510431},{"date":"2024-08-02","current":-3.12148,"twenty":-8.510893,"median":-6.387862,"eighty":-3.652511,"marketCap":1794461610},{"date":"2024-08-09","current":-2.9997,"twenty":-8.480176,"median":-6.325017,"eighty":-3.53511,"marketCap":1735946557},{"date":"2024-08-16","current":-3.214159,"twenty":-8.413826,"median":-6.28512,"eighty":-3.427,"marketCap":1860778669},{"date":"2024-08-23","current":-6.604067,"twenty":-8.372166,"median":-6.272718,"eighty":-3.478589,"marketCap":2129947911},{"date":"2024-08-30","current":-6.163541,"twenty":-8.347233,"median":-6.28512,"eighty":-3.497821,"marketCap":2001214795},{"date":"2024-09-06","current":-5.314921,"twenty":-8.300967,"median":-6.252611,"eighty":-3.516857,"marketCap":1726510663},{"date":"2024-09-13","current":-5.032211,"twenty":-8.277822,"median":-6.194778,"eighty":-3.53511,"marketCap":1630395636},{"date":"2024-09-20","current":-5.111432,"twenty":-8.256206,"median":-6.170373,"eighty":-3.56099,"marketCap":1665993794},{"date":"2024-09-27","current":-6.057967,"twenty":-8.195708,"median":-6.135055,"eighty":-3.605108,"marketCap":1986377216},{"date":"2024-10-04","current":-7.03444,"twenty":-8.180254,"median":-6.166957,"eighty":-3.621517,"marketCap":2296081191},{"date":"2024-10-10","current":-6.311883,"twenty":-8.160101,"median":-6.193894,"eighty":-3.641637,"marketCap":2046894085},{"date":"2024-10-18","current":-9.026405,"twenty":-8.160101,"median":-6.241014,"eighty":-3.658355,"marketCap":2911929324},{"date":"2024-10-25","current":-10.329157,"twenty":-8.288852,"median":-6.25781,"eighty":-3.667517,"marketCap":3331987588},{"date":"2024-11-01","current":-10.068556,"twenty":-8.453817,"median":-6.28512,"eighty":-3.723447,"marketCap":3250111825},{"date":"2024-11-08","current":-11.890039,"twenty":-8.539495,"median":-6.303819,"eighty":-3.748634,"marketCap":3809002906},{"date":"2024-11-15","current":-12.473246,"twenty":-8.638855,"median":-6.337113,"eighty":-3.770095,"marketCap":3965634801},{"date":"2024-11-22","current":-15.548537,"twenty":-8.857338,"median":-6.401271,"eighty":-3.792036,"marketCap":4941024330},{"date":"2024-11-29","current":-16.918042,"twenty":-8.907392,"median":-6.418623,"eighty":-3.798946,"marketCap":5372620800},{"date":"2024-12-06","current":-17.028741,"twenty":-9.08956,"median":-6.440305,"eighty":-3.809963,"marketCap":5395037855},{"date":"2024-12-13","current":-14.037501,"twenty":-9.184661,"median":-6.496848,"eighty":-3.825885,"marketCap":4438576850},{"date":"2024-12-20","current":-10.693671,"twenty":-9.519989,"median":-6.507224,"eighty":-3.843767,"marketCap":3366294395},{"date":"2024-12-27","current":-10.761363,"twenty":-9.613258,"median":-6.510825,"eighty":-3.853605,"marketCap":3384975274},{"date":"2025-01-03","current":-12.815569,"twenty":-9.789285,"median":-6.563121,"eighty":-3.862906,"marketCap":4035069864},{"date":"2025-01-10","current":-14.889249,"twenty":-9.925093,"median":-6.595306,"eighty":-3.863109,"marketCap":4670219750},{"date":"2025-01-17","current":-11.842286,"twenty":-10.213871,"median":-6.606383,"eighty":-3.864484,"marketCap":3717494921},{"date":"2025-01-24","current":-10.786847,"twenty":-10.358151,"median":-6.624251,"eighty":-3.867614,"marketCap":3407392329},{"date":"2025-01-28","current":-10.88357,"twenty":-10.395234,"median":-6.635203,"eighty":-3.869357,"marketCap":3455962615},{"date":"2025-02-07","current":-10.247352,"twenty":-10.395234,"median":-6.668158,"eighty":-3.877648,"marketCap":3235528242},{"date":"2025-02-14","current":-10.714001,"twenty":-10.679993,"median":-6.721699,"eighty":-3.919404,"marketCap":3381239099},{"date":"2025-02-21","current":-14.934496,"twenty":-10.737429,"median":-6.739573,"eighty":-3.995096,"marketCap":4729998562},{"date":"2025-02-28","current":-14.81818,"twenty":-10.833722,"median":-6.801774,"eighty":-4.034059,"marketCap":4677692101},{"date":"2025-03-07","current":-17.375919,"twenty":-11.045086,"median":-6.869978,"eighty":-4.108477,"marketCap":5507123129},{"date":"2025-03-14","current":-16.002657,"twenty":-11.141514,"median":-6.898274,"eighty":-4.166071,"marketCap":5073726736},{"date":"2025-03-21","current":-15.584553,"twenty":-11.292034,"median":-6.914215,"eighty":-4.215924,"marketCap":4939224407},{"date":"2025-03-28","current":-19.960729,"twenty":-11.418322,"median":-6.958518,"eighty":-4.322429,"marketCap":5432399613},{"date":"2025-04-03","current":-17.71685,"twenty":-11.522026,"median":-7.011873,"eighty":-4.393328,"marketCap":4812194430},{"date":"2025-04-11","current":-14.733536,"twenty":-11.702518,"median":-7.03444,"eighty":-4.445369,"marketCap":3975291051},{"date":"2025-04-17","current":-15.831036,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"marketCap":4281657466},{"date":"2025-04-25","current":-18.85387,"twenty":-11.890039,"median":-7.064143,"eighty":-4.482534,"marketCap":5103616142},{"date":"2025-05-02","current":-20.273816,"twenty":-12.024603,"median":-7.138152,"eighty":-4.483904,"marketCap":5499650777},{"date":"2025-05-09","current":-20.37867,"twenty":-12.272607,"median":-7.171338,"eighty":-4.537135,"marketCap":5566901942},{"date":"2025-05-16","current":-19.209634,"twenty":-12.535336,"median":-7.205238,"eighty":-4.575802,"marketCap":5290424932},{"date":"2025-05-23","current":-24.021586,"twenty":-12.71305,"median":-7.273665,"eighty":-4.590948,"marketCap":6635448220},{"date":"2025-05-30","current":-24.266566,"twenty":-12.811921,"median":-7.298393,"eighty":-4.611692,"marketCap":6732588791},{"date":"2025-06-06","current":-26.139049,"twenty":-13.04892,"median":-7.396066,"eighty":-4.640938,"marketCap":7270598106},{"date":"2025-06-13","current":-29.74055,"twenty":-13.19671,"median":-7.470293,"eighty":-4.681154,"marketCap":8275629397},{"date":"2025-06-20","current":-28.050034,"twenty":-13.86335,"median":-7.533906,"eighty":-4.700982,"marketCap":7789926543},{"date":"2025-06-27","current":-24.148232,"twenty":-14.651862,"median":-7.597268,"eighty":-4.71884,"marketCap":6725116440},{"date":"2025-07-04","current":-23.234874,"twenty":-14.895898,"median":-7.634748,"eighty":-4.738772,"marketCap":6471056485},{"date":"2025-07-11","current":-22.291445,"twenty":-15.089879,"median":-7.696392,"eighty":-4.760215,"marketCap":6202051828},{"date":"2025-07-18","current":-26.31753,"twenty":-15.471722,"median":-7.782262,"eighty":-4.775945,"marketCap":7316474020},{"date":"2025-07-25","current":-25.476909,"twenty":-15.613487,"median":-7.864399,"eighty":-4.786942,"marketCap":7108532126},{"date":"2025-08-01","current":-24.329935,"twenty":-15.664049,"median":-8.108989,"eighty":-4.797184,"marketCap":6746559201},{"date":"2025-08-08","current":-25.903798,"twenty":-15.966112,"median":-8.199572,"eighty":-4.803824,"marketCap":7200950746},{"date":"2025-08-15","current":-26.404653,"twenty":-16.351868,"median":-8.297938,"eighty":-4.809409,"marketCap":6923694888},{"date":"2025-08-22","current":-24.957996,"twenty":-16.76437,"median":-8.37361,"eighty":-4.821672,"marketCap":6523837408},{"date":"2025-08-29","current":-23.625619,"twenty":-17.081215,"median":-8.510167,"eighty":-4.847599,"marketCap":6205046052},{"date":"2025-09-05","current":-24.661552,"twenty":-17.4013,"median":-8.538507,"eighty":-4.876556,"marketCap":6470705516},{"date":"2025-09-12","current":-20.300804,"twenty":-17.709582,"median":-8.5673,"eighty":-4.894937,"marketCap":5336119539},{"date":"2025-09-19","current":-22.387755,"twenty":-18.502396,"median":-8.659194,"eighty":-4.936492,"marketCap":5880503891},{"date":"2025-09-26","current":-23.755076,"twenty":-18.883269,"median":-8.853357,"eighty":-5.007141,"marketCap":6223463577},{"date":"2025-10-03","current":-26.75639,"twenty":-19.317505,"median":-8.86952,"eighty":-5.027379,"marketCap":7026491136},{"date":"2025-10-10","current":-24.099943,"twenty":-19.58973,"median":-8.892896,"eighty":-5.032211,"marketCap":6319659587},{"date":"2025-10-17","current":-21.756329,"twenty":-19.863851,"median":-8.951685,"eighty":-5.039347,"marketCap":5700659177},{"date":"2025-10-24","current":-19.051807,"twenty":-20.078316,"median":-9.089652,"eighty":-5.055065,"marketCap":4993827628},{"date":"2025-10-31","current":-18.736648,"twenty":-20.048899,"median":-9.127121,"eighty":-5.062023,"marketCap":4918543795},{"date":"2025-11-07","current":-16.723664,"twenty":-19.976892,"median":-9.288548,"eighty":-5.072031,"marketCap":4387374524},{"date":"2025-11-14","current":-21.334357,"twenty":-19.976892,"median":-9.450099,"eighty":-5.103965,"marketCap":5612828038},{"date":"2025-11-21","current":-24.191268,"twenty":-20.149,"median":-9.60082,"eighty":-5.127222,"marketCap":6361483939},{"date":"2025-11-28","current":-26.084626,"twenty":-20.359324,"median":-9.675041,"eighty":-5.135712,"marketCap":6884288339},{"date":"2025-12-05","current":-26.466998,"twenty":-20.455357,"median":-9.837458,"eighty":-5.145701,"marketCap":6997214089},{"date":"2025-12-12","current":-24.949582,"twenty":-21.347937,"median":-9.89595,"eighty":-5.163276,"marketCap":6608247616},{"date":"2025-12-19","current":-24.323785,"twenty":-21.641075,"median":-10.068556,"eighty":-5.198656,"marketCap":6457679948},{"date":"2025-12-24","current":-21.98676,"twenty":-21.77214,"median":-10.125423,"eighty":-5.211333,"marketCap":5855409280},{"date":"2026-01-02","current":-21.259193,"twenty":-21.755726,"median":-10.240347,"eighty":-5.219085,"marketCap":5683929436},{"date":"2026-01-09","current":-20.81628,"twenty":-21.755726,"median":-10.329157,"eighty":-5.237411,"marketCap":5579368556},{"date":"2026-01-16","current":-22.553102,"twenty":-21.77741,"median":-10.348222,"eighty":-5.302498,"marketCap":6064531040},{"date":"2026-01-23","current":-24.816667,"twenty":-21.782791,"median":-10.364083,"eighty":-5.307592,"marketCap":6666801708},{"date":"2026-01-30","current":-21.232192,"twenty":-21.93483,"median":-10.54642,"eighty":-5.31773,"marketCap":5729936224},{"date":"2026-02-06","current":-19.168838,"twenty":-21.847156,"median":-10.680397,"eighty":-5.331073,"marketCap":5186219648},{"date":"2026-02-13","current":-19.151587,"twenty":-21.790077,"median":-10.7243,"eighty":-5.344782,"marketCap":5211314259},{"date":"2026-02-20","current":-20.225911,"twenty":-21.786448,"median":-10.738136,"eighty":-5.355348,"marketCap":5495719852},{"date":"2026-02-27","current":-20.250109,"twenty":-21.782736,"median":-10.786847,"eighty":-5.38165,"marketCap":5562638816},{"date":"2026-03-06","current":-19.984902,"twenty":-21.771543,"median":-10.928523,"eighty":-5.410462,"marketCap":5445530630},{"date":"2026-03-13","current":-22.811571,"twenty":-21.771543,"median":-11.041852,"eighty":-5.454036,"marketCap":6244375753},{"date":"2026-03-20","current":-23.005636,"twenty":-21.897901,"median":-11.062683,"eighty":-5.524583,"marketCap":6273652800},{"date":"2026-03-24","current":-21.709079,"twenty":-21.860972,"median":-11.10107,"eighty":-5.557677,"marketCap":5922328243}],"updateTime":1774409242061},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02105\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1148177036","title":"LAEKNA-B (02105): First Patient Dosed in Phase I Multiple-Dose Expansion Study of LAE102 for Obesity Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1148177036","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148177036?lang=en_us&edition=fundamental","pubTime":"2025-12-22 08:26","pubTimestamp":1766363171,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) announced that the group has initiated patient enrollment for a Phase I multiple-dose expansion study of LAE102 targeting obesity treatment in China and has completed dosing the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2593179225","title":"Laekna Inc. Begins Phase I Multiple Dose Study of LAE102 for Obesity Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2593179225","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593179225?lang=en_us&edition=fundamental","pubTime":"2025-12-22 08:15","pubTimestamp":1766362549,"startTime":"0","endTime":"0","summary":"Laekna Inc. has announced the commencement of a Phase I multiple dose expansion study of LAE102 for the treatment of obesity in China. The study is a randomized, double-blind, placebo-controlled trial involving 60 overweight or obese subjects, who will receive either LAE102 or placebo over a six-month period. The primary objectives are to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of LAE102. This trial follows positive one-month results from an earlier multiple ascending dose  study. Results from the current study have not yet been presented and will be available in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laekna Inc. published the original content used to generate this news brief via II","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL86mPw4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2591993396","title":"Laekna Completes Patient Enrollment In LAE002 Breast Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2591993396","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591993396?lang=en_us&edition=fundamental","pubTime":"2025-12-15 10:32","pubTimestamp":1765765937,"startTime":"0","endTime":"0","summary":"Laekna  completed patient enrollment in the phase 3 clinical trial of LAE002 to treat breast cancer, according to a Hong Kong bourse filing Monday.The late-stage trial, called AFFIRM-205, will study LAE002 in combination with fulvestrant. Topline data is expected in the first half of 2026, followed by a new drug application with Chinese regulators later in the year, the firm said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1132712108","title":"LAEKNA-B (02105): Enrollment Completed for Phase III Clinical Trial (AFFIRM-205) of LAE002 (Afuresertib) in HR+/HER2- Locally Advanced or Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1132712108","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132712108?lang=en_us&edition=fundamental","pubTime":"2025-12-15 08:20","pubTimestamp":1765758016,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) announced that the group has completed patient enrollment for the Phase III clinical trial AFFIRM-205, evaluating LAE002 (afuresertib) in combination with fulvestrant for the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4203","HR","III","BK4134","BK4225","02105"],"gpt_icon":0},{"id":"2590505982","title":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats up","url":"https://stock-news.laohu8.com/highlight/detail?id=2590505982","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590505982?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:04","pubTimestamp":1765541041,"startTime":"0","endTime":"0","summary":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats upChanges dateline, adds new details in paragraph 19, 20, 27, 36 and 54. The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector currently dominated by Novo Nordisk NOVOb.CO and Eli Lilly LLY.N.Analysts project the industry could rake in $150 billion in annual sales by the next decade.Soaring demand for its obesity treatment has helped Lilly become the first pharmaceutical company to reach","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4N3XI0R0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN8TJ469.HKD","LU0499090636.EUR","IE00B4JS1V06.HKD","AMGN","MRK","LU0345777147.USD","LU0256863902.USD","03933","LU0106261372.USD","LU1035775433.USD","LU0130517989.USD","OPK","LU0964806797.USD","LU0211328371.USD","SRRK","SG9999002224.SGD","IE00BJJMRX11.SGD","LU0823434583.USD","LU2106854487.HKD","LU1061106388.HKD","LU0306806265.USD","LU1720051017.SGD","03165","IE00BK4W5M84.HKD","MTSR","IE0002141913.USD","LU1323610961.USD","600196","IE0005OL40V9.USD","02105","BK0188","SG9999014906.USD","ALT","AZN.UK","LU1003077747.HKD","LU1989771016.USD","SG9999015986.USD","BK0028","SG9999013999.USD","LLY","SGXZ99366536.SGD","00656","VKTX","BK4566","LU1989772840.SGD","03692","BK0187","GPCR","IE00BJLML261.HKD"],"gpt_icon":1},{"id":"1135675546","title":"LAEKNA-B (02105): Xie Ling and Zhou Jian Appointed as Members of Nomination and Corporate Governance Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1135675546","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135675546?lang=en_us&edition=fundamental","pubTime":"2025-12-12 18:06","pubTimestamp":1765533995,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) announced that, effective December 12, 2025, Executive Director Ms. Xie Ling and Independent Non-Executive Director Mr. Zhou Jian have been appointed as members of the company's Nomination and Corporate Governance Committee.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2590937577","title":"Laekna Inc. Files Director List with HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2590937577","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590937577?lang=en_us&edition=fundamental","pubTime":"2025-12-12 18:03","pubTimestamp":1765533789,"startTime":"0","endTime":"0","summary":"Laekna Inc., a biopharmaceutical company listed on the Hong Kong Stock Exchange , has filed an updated list of directors and their roles. The Board is chaired by Dr. LU Chris Xiangyang, who also serves as Chief Executive Officer. Other executive directors include Ms. XIE Ling and Dr. GU Xiang-Ju Justin. The non-executive directors are Dr. WANG David Guowei and Mr. SUN Yuan. Independent non-executive directors comprise Dr. YIN Xudong, Dr. LI Min, and Mr. ZHOU Jian. Committee memberships are as follows: Dr. LU Chris Xiangyang chairs the Nomination and Corporate Governance Committee, with Ms. XIE Ling, Dr. LI Min, and Mr. ZHOU Jian as members. Mr. ZHOU Jian chairs the Audit Committee, joined by Dr. WANG David Guowei and Dr. LI Min as members. The Remuneration Committee is chaired by Dr. YIN Xudong, with Ms. XIE Ling and Mr. ZHOU Jian serving as members.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL3blG8z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2590157764","title":"Laekna Inc. Appoints Xie Ling and Zhou Jian to Nomination and Corporate Governance Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2590157764","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590157764?lang=en_us&edition=fundamental","pubTime":"2025-12-12 18:01","pubTimestamp":1765533689,"startTime":"0","endTime":"0","summary":"Laekna Inc. has announced changes to its Nomination and Corporate Governance Committee. Ms. XIE Ling and Mr. ZHOU Jian have been appointed as new members, joining Dr. LU Chris Xiangyang, Dr. YIN Xudong, and Dr. LI Min. Dr. LU Chris Xiangyang will serve as the committee's chairperson.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laekna Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL6LDJ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1130982436","title":"HK Stock Movement | LAEKNA-B (02105) Rises Over 5% in Early Trading, LAE002 Expected to Submit NDA in First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1130982436","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130982436?lang=en_us&edition=fundamental","pubTime":"2025-12-04 10:08","pubTimestamp":1764814097,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) surged more than 5% in early trading, reaching HK$16.9 with a turnover of HK$28.7 million. The company recently signed an exclusive agreement with Qilu Pharmaceutical, granting Qilu...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1134728285","title":"10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=1134728285","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134728285?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:38","pubTimestamp":1764761917,"startTime":"0","endTime":"0","summary":"On December 3, 2025, the \"10th Zhitong Capital Market Annual Conference & Listed Companies Awards Ceremony,\" jointly hosted by leading Hong Kong and U.S. stock information platform Zhitong Finance...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422952.EUR","LU0315179316.USD","LU1226287875.USD","LU0823039010.USD","HK0000500386.USD","LU1861214812.USD","01333","BK1114","02627","06618","SG9999000475.SGD","BK1116","LU0823426480.USD","LU1719994722.HKD","LU2097828714.EUR","BK1609","LU2294711713.HKD","09985","LU0588546209.SGD","02177","BK1523","BK1587","09992","BK1526","06996","LU0819123356.HKD","00382","LU2348773727.SGD","HYDD.SI","LU0164939612.USD","09877","02273","LU0620787316.HKD","SG9999011746.SGD","SG9999001069.SGD","02670","BK1104","HK0000252160.HKD","BK1142","LU0261947096.USD","LU0211977185.USD","IE00B031HY20.USD","LU0345775950.USD","LU2506951792.HKD","02567","BK1520","IE0034224299.USD","06963","BK1593","LU0049112450.USD","09678","01651","09923","IE00BMCWC346.EUR","03650","LU0823038988.USD","SG9999015986.USD","02587","03998","IE00B29SXG58.USD","LU0702159699.USD","LU1807302812.USD","01762","BK1132","LU0449515922.USD","00017","LU1951186391.HKD","LU2298064838.USD","03836","BK1124","BK1258","LU2153592121.USD","02419","00135","BK1171","BK1575","BK1230","06060","BK1606","LU1770036033.HKD","LU2242644610.SGD","BK1518","09860","SG9999015952.SGD","LU0819121731.USD","BK1188","SG9999001051.SGD","02552","BK1549","BK1178","02525","HK0000320223.HKD","BK1186","02598","BK1167","LU0164872284.USD","02590","BK1585","BK1610","LU0516423174.USD","09919","82020","BK1119","LU0531970944.HKD","LU0871576103.HKD","BK1200","06988","02551","06913","BK1618","IE00BQXX3D17.EUR","LU0052750758.USD","LU0254981946.USD","BK1222","LU0128525689.USD","LU0511384066.AUD","BK1189","LU1039395188.USD","LU0251144936.SGD","01907","LU2249611893.SGD","09911","ANPDY","BK1591","LU0823426308.USD","BK1571","LU0072462343.USD","02629","BK1582","BK1134","BK1607","BK1169","LU0244354667.USD","LU1917777945.USD","LU1993786604.SGD","LU0165289439.USD","LU0329678337.USD","BK1170","BK1519","IE00BGV7N243.SGD","LU1770034418.SGD","02171","00020","BK1215","BK1604","LU0516422440.USD","03396","LU1497734951.SGD","LU0149721374.USD","LU0501845795.SGD","LU0348784397.USD","BK1557","LU0561508036.HKD","06608","LU0634319403.HKD","LU2357125470.USD","02142","SG9999002463.SGD","BK1605","LU0052756011.USD","BK1194","LU0979878070.USD","09690","BK1164","LU1508157978.USD","00460","02105","02498","IE00BVYPNP33.GBP","02382","01877","02488","LU1974910355.USD","02250","LU0348735423.USD","LU2449936058.SGD","BK1540","LU1868838027.USD","IE0003851619.USD","BK1111","BK1512","LU2106854487.HKD","LU0289960550.SGD","LU0823437842.USD","03680","LU0107464264.USD","IE00BQXX3C00.GBP","09699","02018","LU0173614495.USD","LU0175139822.USD","LU0791590937.USD","LU0417516902.SGD","00798","LU2506952253.HKD","LU0823414551.USD","BK1131","IE00B8L5B284.USD","LU1868837722.USD","01405","01585","LU1880383440.USD","BYDDY","LU2008162690.USD","09956","LU0082770016.SGD","BK1179","LU0011963245.USD","LU0048575426.USD","LU0348783233.USD","LU0345776255.USD","06069","06160","02121","86618","BK1127","LU0737861699.HKD","LU1808992512.USD","BK1554","00512","LU0067412154.USD","BK1528","LU1481107354.HKD","LU0791591158.USD","LU0449509016.USD","LU0831093199.SGD","00861","03677","LU1939255532.USD","00003","LU0593848301.USD","LU0499858602.USD","BK1126","02256","LU0048580855.USD","LU2125910500.SGD","LU3063872942.SGD","02469","03145","BK1110","LU0856984785.SGD","01458","LU0072913022.USD","BK1616","LU1226287529.USD","LU0269904917.USD","BK1147","00875","03800","LU0488056044.USD","00305","LU0502904849.HKD","LU0499858438.USD","LU1831875114.USD","BK1578","LU0228659784.USD","LU2348774022.SGD","BK1589","LU1152091168.USD","06855","00300","LU0762540952.USD","LU1813983027.USD","01448","LU2097828557.USD","LU0320764599.SGD","LU0540923850.HKD","00867","BK1615","LU0039217434.USD","82331","LU2177674079.SGD","09660","LU0463099449.HKD","LU0572944931.SGD","IE00BPRC5H50.USD","02158","LU0823397285.USD","SG9999006514.SGD","LU0289961442.SGD","00826","06657","SG9999004311.SGD","LU1969619763.USD","LU2023250504.SGD","BK1109","LU0048597586.USD","LU1211504680.USD","01276","LU0865486749.SGD","BK1590","LU2045819591.USD","BK1588","02420","80992","BK1553","LU0611395673.USD","00960","IE00BGHQDM52.EUR","02453","BK1209","01471","02400","BK1193","02858","LU0348827113.USD","LU1226288170.HKD","SGXZ62798434.SGD","02145","LU1497733557.USD","LU0274383008.USD","01640","01119","80020","LU2778985437.USD","IE0031814852.USD","BK1198","01093","BK1100","01735","BK1214","02431","02886","002594","LU2097828631.EUR","BK1140","BK1125","BK1240","09880","LU0880133367.SGD","LU2460026573.USD","BK1550","00267","LU1366334578.USD","BK1619","BK1095","LU1102505762.USD","LU2097828474.EUR","06613","01911","09961","06677","LU0417516738.SGD","BK1530","BK1233","BK1548","02315","BK1552","SG9999000418.SGD","LU0531971595.HKD","LU0594300179.USD","LU1267930227.SGD","IE00B0JY6N72.USD","00451","BK1594","06058","LU0348767384.USD","LU2543165471.USD","LU0264606111.USD","LU0605514214.HKD","BK1541","BK1608","IE00BVYPNQ40.USD","LU1048588211.SGD","LU0588545730.USD","LU1226287792.SGD","SG9999002950.SGD","BK1158","BK1239","LU0541501648.USD","06168","LU1634259391.SGD","LU0456827905.SGD","01809","BK1516","LU0348805143.USD","01939","02460","LU0456846285.SGD","LU1251922891.USD","03658","BK1596","02279","BK1247","LU1366334651.USD","BK1161","LU0348825331.USD","BK1221","SG9999000459.SGD","00699","HK0000252152.HKD","LU0823397103.USD","LU1115378108.SGD","BK1521","IE00B031J352.USD","BK1227","BK1531","BK1586","LU0307460666.USD","LU0708995583.HKD","SG9999015945.SGD","SG9999015978.USD","LU2238339852.HKD","LU1282649067.USD","LU0737861772.HKD","LU1242518931.SGD","BK1141","LU1046422090.SGD","00302","02411","LU0164880469.USD","BK1154","06100","06609","LU1224709979.USD","BK1191","LU0043850808.USD","LU0359202008.SGD","03681","01600","02228","IE0008369823.USD","LU1152091754.HKD","LU0828238088.HKD","02616","SGXZ90724238.SGD","BK1556","LU0229945570.USD","LU2039709279.SGD","06138","IE00BYV24P56.USD","LU2153591404.USD","LU0287142896.SGD","BK1504","BK1577","BK1197","BK1150","BK1539","LU2476274308.USD","LU0329678170.USD","LU0326950275.SGD","LU0214875030.USD","LU0588545904.SGD","02565","09959","02509","BK1253","LU0054237671.USD","LU2360107325.USD","01969","09990","09996","LU0828237510.HKD","BK1509","LU0868486357.SGD","02020","LU1242518857.USD","LU0509642566.USD","BK1148","LU0051755006.USD","02331","00656","BK1168","BK1527","02155","81211","LU0516423091.SGD","LU1868837565.USD","02190","LU0261950470.USD","02511","LU0314109678.HKD","02268","LU0640798160.USD","01211","LU0315178854.USD","BK1144","LU0084288322.USD","LU0594300419.USD","LU0359201612.USD","09927","00777","00136","01117","BK1195","09890","BK1515","LU1166156734.SGD","LU1328277881.USD","LU1282649810.SGD","BK1524","BK1564","BK1595","00384","BK1136","00992","LU0572939691.SGD","IE00B5MMRT66.SGD","03896","SG9999004220.SGD","BK1555","06186","BK1617","LU0455707207.USD","02150","LU0516422366.SGD","LU1235295612.USD","LU0348766576.USD","02276","LU1961090484.USD","LU1720050803.USD","09878","BK1225","BK1560","02556","00363","LU1008478684.HKD","01818","SG9999002562.SGD","BK1579","SG9999001226.SGD","IE0032431581.USD","BK1613","LU1675838814.USD","SG9999014674.SGD","02157","01177","02197","SG9999001093.SGD","BK1143","06090","01952","00884","HK0000320264.USD","02380","BK1212","01681","09639","02298","BK1190","LU0823414478.USD","01384","BK1207","BK1542","LU0650527681.SGD","LU1188198961.HKD","LU0054450605.USD","02650","02013","LU1023057109.AUD","02451","LU0505663152.USD","LU2097828805.USD","BK1216","LU0359201885.HKD","SG9999003461.SGD","02595","02436","LU0384037296.USD","BK1597","LU0164865239.USD","SG9999001903.USD","BK1257","BK1544","09636","LU1880383366.USD","02096","BK1155","LU1497733631.SGD","02696","BK1228","HK0000306701.USD","LNVGY","03939","BK1224","BK1574","LU0588545490.SGD","LU2399975544.HKD","01070","BK1160","IE00B0169L03.USD","BK1117","LU1634259557.SGD","BK1235","01440","06683","01880","03709","LU2663582299.SGD","01378","01833","LU1303224171.USD","LU2488822045.USD","BK1151","HK0000306685.HKD","01783","LU2424517915.HKD","BK1522","BK1139","LU0143863784.USD","BK1229","LU0431992006.USD","BK1096","06862","IE00B543WZ88.USD","01318","LU0259732245.USD","LU0543330566.HKD","LU1102505929.USD","LU1956131251.USD","01530","LU0310800965.SGD","BK1598","BK1592","SG9999006597.SGD","BK1219","LU1226288253.USD","LU0140636845.USD","LU0327786744.USD","LU0370786039.SGD","BK1583","LU0143863198.USD","BK1566","HK0000165453.HKD","IE00BD6J9T35.USD","BK1163","LU2328871848.SGD","LU0251143458.SGD","BK1137","LNNGY","BK1502","SG9999002828.SGD","LU1328615791.USD","06821","IE0008368742.USD","BK1175","IE0009570106.USD","BK1183","LU1981816686.USD","LU0261950983.USD","00999","06633","LU1861219969.SGD","01164","IE0003795394.USD","09955","LU0541502299.USD","LU0572940350.SGD","06919","02100","03738","01520","LU2476274720.SGD","LU0289739343.SGD","IE00BZ08YT58.USD","BK1237","06086","LU1794554557.SGD","09926","02506","LU1960683339.HKD","BK1128","02167","LU0082770016.USD","02533","SGXZ86797644.SGD","IE00BQXX3F31.USD","LU1522347837.USD","BK1600","LU0469268626.HKD","01519","02889","BK1500","BK1559","02057","BK1184","00855","LU0231483743.USD","IE00BZ08YR35.GBP","IE00B8HQ1Z84.USD","LU0417516571.SGD","01739","02392","BK1220","IE00BZ08YS42.EUR","00666","01773"],"gpt_icon":1},{"id":"1172872567","title":"Laekna, Inc. (02105) Reports Unchanged Share Structure in November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1172872567","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172872567?lang=en_us&edition=fundamental","pubTime":"2025-12-03 17:25","pubTimestamp":1764753950,"startTime":"0","endTime":"0","summary":"Laekna, Inc. (02105) published its monthly return detailing the share capital structure for the period ended 30 November 2025. The authorized share capital remained at 5,000,000,000 ordinary shares...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105"],"gpt_icon":0},{"id":"1177117741","title":"HK Stock Movement | LAEKNA-B (02105) Surges Over 6%, Industry Expects LAE002's Peak Sales in China to Reach RMB 2 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1177117741","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177117741?lang=en_us&edition=fundamental","pubTime":"2025-12-01 11:30","pubTimestamp":1764559816,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) rose more than 6%, with a gain of 4.92% at the time of writing, trading at HK$17.27 and a turnover of HK$32.15 million. On November 12, LAEKNA announced the licensing of its breast...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCHI","YINN","ASHS","02105","BK1161","BK4614","ASHR","BK4585","CHAU","FXI","BK4588","CQQQ","CWEB","DRAG","HXC","KWEB"],"gpt_icon":1},{"id":"1168384821","title":"HK Stock Movement | LAIKNA-B (02105) Surges Over 15%, Up 40% This Month Following BD Deal for LAE002","url":"https://stock-news.laohu8.com/highlight/detail?id=1168384821","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168384821?lang=en_us&edition=fundamental","pubTime":"2025-11-27 10:32","pubTimestamp":1764210751,"startTime":"0","endTime":"0","summary":"LAIKNA-B (02105) surged more than 15%, extending its monthly gain to over 40%. At the time of writing, the stock rose 15.38% to HK$16.95, with a turnover of HK$58.22 million. The rally follows the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2586724475","title":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats up","url":"https://stock-news.laohu8.com/highlight/detail?id=2586724475","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586724475?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:39","pubTimestamp":1764077944,"startTime":"0","endTime":"0","summary":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats upRewrites paragraph 1, adds Lilly valuation milestone in paragraph 3, updates with Novo trial details in paragraphs 9-0. Promising results of Novo Nordisk's NOVOb.CO experimental obesity drug, amycretin, from a mid-stage trial could give the drugmaker much-needed heft to reclaim lost ground in the weight-loss market, which is projected to reach $150 billion by next decade.Novo said the drug appeared safe and well tolerated, with mostly mild-to-moderate gastrointestinal side effects. Late-stage trials are planned for 2026. Amycretin has a dual-mode action, targeting GLP-1 and amylin hormones.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL4N3X10QM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN.UK","SRRK","SG9999011175.SGD","LU0738911758.USD","LU0109391861.USD","AMGN","GPCR","LU2746668461.USD","LU0964806797.USD","LU2168564065.EUR","MRK","LU0949170772.SGD","MTSR","03165","LU2168563687.JPY","OPK","LU0265550359.USD","VKTX","LU0079474960.USD","LU1069347547.HKD","LU0553294199.USD","LU0820561909.HKD","BK4592","LU0094547139.USD","LU1023059063.AUD","LU1061106388.HKD","02105","03933","IE00B4R5TH58.HKD","LU1057294990.SGD","LU1066051225.USD","SG9999013999.USD","ALT","LU0353189680.USD","LU2265009873.SGD","SG9999015945.SGD","IE0004445239.USD","SG9999015986.USD","SG9999014542.SGD","IE00BLSP4239.USD","LU0823416689.USD","LU0225771236.USD","LU0198837287.USD","LU0557290698.USD","LU2168564149.EUR","03692","LU1551013342.USD","LU2063271972.USD"],"gpt_icon":1},{"id":"1117424956","title":"Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast","url":"https://stock-news.laohu8.com/highlight/detail?id=1117424956","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117424956?lang=en_us&edition=fundamental","pubTime":"2025-11-18 08:56","pubTimestamp":1763427395,"startTime":"0","endTime":"0","summary":"As the fourth technological revolution sweeps across the globe, with AI and large model technologies reaching critical breakthroughs, capital engines are driving the revaluation of Chinese assets at...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1556","LU2778985437.USD","BK1139","BK1193","BK1542","LU0417516902.SGD","BK1137","00305","02533","02670","BK1224","00867","BK1131","IE00BVYPNP33.GBP","LU2476274720.SGD","SG9999015986.USD","BK1221","BK1592","02411","00363","02142","SG9999015952.SGD","02561","SG9999015945.SGD","BK1591","01809","BK1175","BK1209","BK1132","01164","BK1608","BK1183","02420","03738","BK1531","BK1587","IE00BGHQDM52.EUR","LU0348825331.USD","BK1140","01228","BK1155","HK0000500386.USD","BK1142","IE00B543WZ88.USD","03315","LU1497733557.USD","BK1228","BK1171","BK1178","01773","09878","BK1147","02453","BK1191","06677","BK1594","09919","06609","BK1524","09996","09959","09911","LU1634259391.SGD","06682","SG9999004220.SGD","00003","06919","SG9999014674.SGD","01969","BK1583","00382","00855","BK1555","02616","BK1150","LU2460026573.USD","BK1516","LU1522347837.USD","BK1574","BK1104","HK0000252160.HKD","BK1596","BK1194","BK1207","LU1634259557.SGD","SG9999003461.SGD","02157","LU2476274308.USD","02380","09678","00196","01681","BK1163","BK1230","BK1100","01167","BK1586","BK1577","BK1613","02171","LU1808992512.USD","00552","02256","06633","09860","02886","BK1606","BK1124","SG9999001069.SGD","LU0348766576.USD","BK1619","06996","LU1497734951.SGD","02105","02167","01651","03658","01333","02567","02096","BK1529","02509","BK1521","LU1497733631.SGD","BK1579","BK1527","BK1148","01762","BK1552","BK1595","IE00BMCWC346.EUR","BK1188","IE00BYV24P56.USD","BK1144","00699","BK1216","03145","BK1585","BK1219","BK1609","BK1109","01783","BK1110","BK1539","02268","BK1618","02431","00861","06069","BK1575","BK1582","BK1530","06660","00826","BK1116","BK1125","01318","01907","LU2488822045.USD","06100","IE00B5MMRT66.SGD","SG9999002950.SGD","BK1095","06608","BK1593","02511","BK1506","BK1578","00290","BK1225","02177","02279","IE00BPRC5H50.USD","BK1229","BK1161","02858","02551","02587","BK1186","BK1258","00604","HK0000252152.HKD","IE00BVYPNQ40.USD","06090","BK1141","BK1114","00302","BK1202","02627","BK1500","BK1518","SG9999015978.USD","LU0348767384.USD","02488"],"gpt_icon":0},{"id":"1194686074","title":"LAEKNA-B (02105) Surges Over 9% Again as Breast Cancer Drug Candidate LAE002 Secures 2.045 Billion Yuan BD Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1194686074","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194686074?lang=en_us&edition=fundamental","pubTime":"2025-11-17 14:56","pubTimestamp":1763362581,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) rose over 9% again, with a 6.71% increase at the time of writing, trading at HK$14.32 and a turnover of HK$92.66 million. On November 12, LAEKNA licensed the China rights for its...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","BK1161"],"gpt_icon":0},{"id":"1154421719","title":"HK Stock Movement | LAIKNA-B (02105) Rises Nearly 7% Against Market Trend, Secures RMB 2.045 Billion BD Deal for Star Breast Cancer Target, Strengthens Core Business in Muscle Gain and Fat Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1154421719","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154421719?lang=en_us&edition=fundamental","pubTime":"2025-11-14 10:30","pubTimestamp":1763087419,"startTime":"0","endTime":"0","summary":"LAIKNA-B (02105) surged nearly 7% against the broader market trend. At the time of writing, the stock was up 2.88%, trading at HK$19 with a turnover of HK$27.711 million. The company announced via...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","BK1161"],"gpt_icon":0},{"id":"1104226063","title":"HK Movers | Biomedical Stocks Jump With CStone Pharmaceuticals up 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1104226063","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104226063?lang=en_us&edition=fundamental","pubTime":"2025-11-14 10:24","pubTimestamp":1763087071,"startTime":"0","endTime":"0","summary":"Biomedical stocks jumped in Hong Kong. CStone Pharmaceuticals rose 13%; Ascletis Pharma rose 11%; Sirnaomics rose 9%; Laekna rose 7%; PegBio Co rose 6%; Immunotech Biopharm rose 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"5d27790606b64b3231c65f4df87c0e89","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","02257","02565","01672","02105","02616"],"gpt_icon":0},{"id":"1198788693","title":"HK Movers | Biomedical Stocks Jump With BeOne Medicines and Biocytogen up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198788693","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198788693?lang=en_us&edition=fundamental","pubTime":"2025-11-13 09:52","pubTimestamp":1762998775,"startTime":"0","endTime":"0","summary":"Biomedical stocks jumped in Hong Kong. BeOne Medicines and Biocytogen Pharmaceuticals rose 7%; 3SBio rose 6%; Innovent Biologics and Duality Biotherapeutics rose 5%; Laekna rose 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"93ca2ea8f560905425dc4dda4a045e37","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","01530","09606","02105","06160","02315"],"gpt_icon":0},{"id":"2582534893","title":"BUZZ-HK-listed Laekna jumps most in 7 weeks on Qilu licence deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2582534893","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582534893?lang=en_us&edition=fundamental","pubTime":"2025-11-12 11:29","pubTimestamp":1762918156,"startTime":"0","endTime":"0","summary":"BUZZ-HK-listed Laekna jumps most in 7 weeks on Qilu licence deal   ** Shares of Laekna Inc 2105.HK jump 8.5% to HK$12.28, their biggest intraday pct gain since September 26 ** Stock hit its highest point since November 5, and on track for third consecutive session of gains, if current trend holds** The developer of innovative therapies for cancer, liver diseases and obesity said it has granted China's Qilu Pharmaceutical an exclusive licence for research, development, and commercialisation of breast and prostate cancer treatment LAE002  in China** Says the company is entitled to receive upfront and clinical development milestone payments up to 530 million yuan   upon new drug application approval in China** Says the company is eligible to receive up to 2.045 billion yuan  in total in upfront and milestone payments and is entitled to receive tiered royalties on future net sales of LAE002  at percentages ranging from the low teens to the low twenties** YTD, Laekna shares up 28.9%, Hang S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}]}}